Get started

St. Eugenio Hospital

Homepage: aslrmc.com
Alternate names: Ospedale S. Eugenio, Sant'Eugenio Hospital
ROR: 03h1gw307
OpenAlex ID: I4210143032
Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study
2010 · Michele Cavo, Paola Tacchetti, et al. · The Lancet · 819
Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial
2006 · Antonio Palumbo, Sara Bringhen, et al. · The Lancet · 809
Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease
2007 · A. Stefani, A. M. Lozano, et al. · Brain · 807
PDF
Locomotor Primitives in Newborn Babies and Their Development
2011 · Nadia Dominici, Yuri P. Ivanenko, et al. · Science · 650
Levofloxacin to Prevent Bacterial Infection in Patients with Cancer and Neutropenia
2005 · Giampaolo Bucaneve, Alessandra Micozzi, et al. · New England Journal of Medicine · 648
PDF
Ponatinib efficacy and safety in Philadelphia chromosome–positive leukemia: final 5-year results of the phase 2 PACE trial
2018 · Jorge E. Cortes, Dong-Wook Kim, et al. · Blood · 592
PDF
Impaired Cerebral Vasoreactivity and Risk of Stroke in Patients With Asymptomatic Carotid Artery Stenosis
2000 · Mauro Silvestrini · JAMA · 588
Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura
2001 · Roberto Stasi, Adalberto Pagano, et al. · Blood · 549
Treatment of Relapsing Mild-to-Moderate Ulcerative Colitis With the Probiotic VSL#3 as Adjunctive to a Standard Pharmaceutical Treatment: A Double-Blind, Randomized, Placebo-Controlled Study
2010 · Antonio Tursi, Giovanni Brandimarte, et al. · The American Journal of Gastroenterology · 489
Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial
2008 · Carlo Di Mario, Dariusz Dudek, et al. · The Lancet · 437
Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell–depleting therapy with rituximab
2008 · Roberto Stasi, Nichola Cooper, et al. · Blood · 410
Factors associated with outcomes of unrelated cord blood transplant: Guidelines for donor choice
2004 · Eliane Gluckman, Vanderson Rocha, et al. · Experimental Hematology · 394
PDF
Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients
2014 · Wilma Barcellini, Bruno Fattizzo, et al. · Blood · 382
PDF
Maintenance Treatment with Recombinant Interferon Alfa-2b in Patients with Multiple Myeloma Responding to Conventional Induction Chemotherapy
1990 · Franco Mandelli, Giuseppe Avvisati, et al. · New England Journal of Medicine · 382
PDF
Dasatinib induces significant hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase
2007 · Francois Guilhot, Jane Apperley, et al. · Blood · 371
PDF
Gemtuzumab Ozogamicin Versus Best Supportive Care in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Unsuitable for Intensive Chemotherapy: Results of the Randomized Phase III EORTC-GIMEMA AML-19 Trial
2016 · Sergio Amadori, Stefan Suciu, et al. · Journal of Clinical Oncology · 362
PDF
Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial
2008 · Antonio Palumbo, Sara Bringhen, et al. · Blood · 358
PDF
Long-Term observation of 208 adults with chronic idiopathic thrombocytopenic purpura
1995 · Roberto Stasi, Elisa Stipa, et al. · The American Journal of Medicine · 353
Amount of spontaneous apoptosis detected by Bax/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML)
2003 · Giovanni Del Poeta, Adriano Venditti, et al. · Blood · 340
Aspirin, Warfarin, or Enoxaparin Thromboprophylaxis in Patients With Multiple Myeloma Treated With Thalidomide: A Phase III, Open-Label, Randomized Trial
2011 · Antonio Palumbo, Michele Cavo, et al. · Journal of Clinical Oncology · 323
PDF
Efficacy of Atorvastatin Reload in Patients on Chronic Statin Therapy Undergoing Percutaneous Coronary Intervention
2009 · Germano Di Sciascio, Giuseppe Patti, et al. · Journal of the American College of Cardiology · 315
PDF
Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial
2015 · Francesca Gay, Stefania Oliva, et al. · The Lancet Oncology · 314
PDF
Response to B-cell–depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura
2007 · Roberto Stasi, Giovanni Del Poeta, et al. · Blood · 301
PDF
The updated European Consensus 2009 on the use of Botulinum toxin for children with cerebral palsy
2009 · Florian Heinen, Kaat Desloovere, et al. · European Journal of Paediatric Neurology · 296
PDF
Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is active in patients with imatinib-resistant or -intolerant accelerated-phase chronic myelogenous leukemia
2007 · Philipp le Coutre, Oliver G. Ottmann, et al. · Blood · 294
PDF
Works count: 2,785
Citation count: 201,700
Year
Topic
Type